SCHEMBL7992967

SCHEMBL7992967

O=C(O)CN(CCc1ccccc1)C(=O)CCCc1ccncc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.56
HDAC3 O15379 1/20 0.50
MAPK1 P28482 1/20 0.50
ADRA1A P35348 1/20 0.50
HDAC4 P56524 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HDAC1 Q13547 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374440 0.84 ALOX5 (0.58) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7206701 0.83 RAB9A (0.45) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL15062810 0.81 KDM4A (0.61) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL1677783 0.79 CA12 (0.55) ALOX5CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7380533 0.78 ALOX5 (0.45) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7444522 0.77 MAPT (0.68) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL11241052 0.77 TDP1 (0.57) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL7992970 0.76 SMN1; SMN2 (0.42) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL21837731 0.76 TDP1 (0.49) ALOX5HDAC3MAPK1ADRA1AHDAC4
SCHEMBL6359725 0.75 TDP1 (0.58) ALOX5HDAC3MAPK1ADRA1AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294549-B1 COMPOUNDS USEFUL FOR INHIBITING RESTENOSIS, ANGIOGENESIS, ATHEROSCLEROSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, INFLAMMATION OR TUMOR GROWTH. MERCK & CO., INC. 2001-09-25 US disclosed